Related references
Note: Only part of the references are listed.Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim
Douglas B. Cines et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients
Mehdi Khellaf et al.
BLOOD (2014)
The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Matthieu Mahevas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia
Sif Gudbrandsdottir et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Immune thrombocytopenia - what are the new treatment options?
Simon Hallam et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists
Bahareh Ghadaki et al.
TRANSFUSION (2013)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia
Mohammad Ali Mashhadi et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Total remission of severe immune thrombocytopenia after short term treatment with romiplostim
Efthymia Vlachaki et al.
HEMATOLOGY REPORTS (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia
Francesco Zaja et al.
BLOOD (2010)
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents
Weili Bao et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production
Diane Nugent et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Rituximab in the treatment of autoimmune haematological disorders
Bernadette Garvey
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Management of adult idiopathic thrombocytopenic purpura
DB Cines et al.
ANNUAL REVIEW OF MEDICINE (2005)
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults
F Borst et al.
ANNALS OF HEMATOLOGY (2004)
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
YF Cheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Overview of 321 patients with idiopathic thrombocytopenic purpura -: Retrospective analysis of the clinical features and response to therapy
GE Pamuk et al.
ANNALS OF HEMATOLOGY (2002)
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
N Cooper et al.
BLOOD (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
Share Paper
